Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc. | 1 | 0 | 0 | 0 | €0.73 | - | - |
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €5.93 | €19.50 | 228.811% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 5 | 0 | €903.00 | €958.32 | 6.126% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €289.65 | €297.31 | 2.645% |
| Gilead Sciences Inc | 11 | 1 | 5 | 0 | €62.28 | €84.81 | 36.179% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €131.10 | €144.44 | 10.179% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €42.20 | €50.00 | 18.483% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €200.80 | €207.72 | 3.444% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.89 | €5.51 | 518.229% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.00 | €21.66 | -5.830% |
| Prothena Corp. plc | 13 | 0 | 1 | 0 | €21.60 | €80.10 | 270.833% |
| Centene Corp. | 15 | 0 | 2 | 0 | €72.08 | €82.57 | 14.554% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €95.50 | €124.85 | 30.731% |
| Stryker Corp. | 23 | 0 | 6 | 0 | €306.00 | €335.03 | 9.487% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €73.14 | €80.00 | 9.379% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.58 | €4.63 | 29.068% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €22.60 | €32.58 | 44.154% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €76.50 | €75.94 | -0.737% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €201.80 | €248.57 | 23.176% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €193.75 | - | - |
| Lightpath Techs A | 4 | 0 | 1 | 0 | €1.24 | €2.78 | 124.565% |
| Cutera Inc. | 1 | 0 | 0 | 0 | €2.38 | €3.00 | 26.263% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.24 | €26.01 | 35.168% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €23.40 | €28.29 | 20.900% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €128.65 | €140.60 | 9.291% |